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Abstract
In this study, the action of 3-nitropropionic acid (3-NP) on the parameters of the cortical and peripheral evoked potentials
was investigated in rats in different administration schemes (20 mg/kg i.p. during recording or 24 h before, and 5× 15 mg/kg
daily 28 days before recording) to elucidate some neurophysiological effects of the substance. Responses in the somatosensory
cortex and in the tail nerve, evoked by peripheral electric stimulation, were recorded in acute preparation under urethane
anaesthesia. Amplitude, latency, and duration of the responses were measured. In rats treated 28 days before recording, latency
of the cortical response was significantly (and the duration slightly) increased by 3-NP. The frequency dependence of the tail
nerve response was more pronounced than that of the cortical response. After acute administration of 3-NP, the amplitude of
the somatosensory evoked potential decreased. With double stimuli, the ratio of the amplitudes of the two responses (relative
fatigue) was treatment-dependent. The relative refractory period of the tail nerve was altered both by acute and subacute 3-NP
treatment. These results may be relevant in 3-NP based disease models but it needs further studies to find possible connections
between the known biochemical effects of 3-NP and the functional neurotoxical changes described. The mode of evoked
response analysis used is, theoretically, applicable for other neurotoxic effects and can be the base of development of functional
biomarkers.
© 2005 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Natural sources of the neurotoxic compound
3-nitropropionic acid (3-NP) are plants (Astragalus
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species, Leguminosae; Johnson et al., 2000), which
sometimes severely or even fatally intoxicate grazing
farm animals (James et al., 1980). The source of
human intoxication may be foodstuffs (sugar cane,
cereals, etc.) infested with moulds of the Arthrinium
and Aspergillus genus (Patocka et al., 2000; Peraica
and Domijan, 2001; Scallet et al., 2001), producing
3-NP. In human victims of 3-NP poisoning, acute
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encephalopathy, followed by dystonia, can develop
even in case of low doses (Liu et al., 1992), and the
cranial CT images indicate lesions of the basal ganglia
(He et al., 1995).
In experimental animals, decreased motor perfor-
mance was seen after 5× 20 mg 3-NP i.p., a dose
very close to ours (Teunissen et al., 2001). Tissue
degeneration, involving primarily the striatum but also
the hippocampus and thalamus, was also described,
both in vitro (Behrens et al., 1995a,b) and in vivo
(following a single dose of 10–30 mg/kg 3-NP;
McCracken et al., 2001), and was interpreted as a
morphological correlate of the motor disorders. This
pathological picture was the basis of introducing 3-NP
treatment in animal modelling of human Huntington’s
disease (Brouillet et al., 1999).
At cellular level, the main effect of 3-NP is
inhibition of succinate dehydrogenase, a key enzyme
of mitochondrial energy conversion (Coles et al.,
1979). This effect develops fast and is not limited
to the sites of morphological damage (Brouillet et
al., 1998). 3-NP was also found to act on synaptic
transmission by influencing NMDA receptors. Due to
the glutamatergic over-excitation resulting, chemically
induced long-term potentiation was seen in in vitro
slices (Calabresi et al., 2001) and excitotoxicity was
observed both in vitro and in vivo (Pubill et al.,
2001).
It is likely that mitochondrial impairment and
enhanced glutamatergic transmission are reflected in
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2.2. Experimental protocols
As the scheme and schedule of dosage had been
shown to substantially influence the effects of 3-NP
(Brouillet et al., 1999), three different protocols were
applied in the present study.
In the subacute protocol, the animals were given
15 mg/kg body mass 3-NP i.p. on five consecutive days
(i.p. LD50 of 3-NP in rats is 67 mg/kg; Pass et al., 1985).
The electrophysiological records – cortical evoked
potential and tail nerve action potential, evoked at var-
ious stimulation frequencies, see Section 2.3 – were
made 4 weeks after the last administration of 3-NP.
Another group of 10 untreated rats served as control.
In the acute experiments, the animals received 3-
NP in a single dose of 20 mg/kg b.m., i.p., 24 h prior
to electrophysiology (cortical evoked potential and tail
nerve action potential evoked with single and double
pulses).
Immediate effects were tested by anesthetizing and
preparing 10 rats first (see below). Here, cortical evoked
potential and tail nerve action potential were recorded
with single pulses. After completing four sets of elec-
trophysiological records, 20 mg/kg b.m. 3-NP was
intraperitoneally given and further 6–8 records were
taken.
2.3. Electrophysiological investigation
The animals were anaesthetized with urethane
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uhe electrical activity of central and peripheral parts of
he nervous system. The aim of the present study was,
herefore, to investigate how the functional neurotoxic
hanges caused by 3-NP administration can be revealed
y neurophysiological recordings in rats.
. Materials and methods
.1. Experimental animals and chemicals
Adult male Wistar rats of ca. 350 g body mass were
btained from the Breeding Center of the University,
nd divided into groups of 10. 3-NP was obtained from
igma–Aldrich GmbH, Steinheim, Germany, in the
ighest purity available. Urethane, used for anesthe-
ia, was purchased from Reanal Fine Chemical Co.,
udapest, Hungary.1000 mg/kg i.p.), placed in a stereotaxic instrument,
nd the left hemisphere was exposed. To record
ortical evoked potentials (EPs) a silver electrode was
laced on the dura over the primary somatosensory
SS) projection area of the whiskers. The contralateral
hisker pad was stimulated by rectangular electric
ulses (ca. 4 V, 0.05 ms). In the periphery, the tail nerve
as stimulated by means of a pair of needle electrodes
nserted at the base of tail. The compound action poten-
ials were recorded distally by another pair of needles
n a distance of 50 mm. The stimuli were delivered
n trains of 50 (whisker pad) or 10 (tail) impulses. To
eveal dynamic interaction between the excitatory pro-
esses, the period time (time between two consecutive
timuli within a train) was varied between 1000 and
00 ms, and double-pulse stimulation, with different
nterstimulus intervals (ISI, 60–300 ms) was also
sed. The recorded responses were averaged, and their
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peak amplitude, peak latency and duration measured.
In the cortical double-pulse records, the second/first
ratio for amplitude and latency was calculated, and
in the tail nerve double-pulse records, relative and
absolute refractory periods (as described by De´si and
Nagymajte´nyi, 1999). Tail nerve conduction velocity
was calculated from the response latency and the
distance of the electrodes. After all recording had been
done, the animals were sacrificed by an overdose of
urethane.
2.4. Statistical analysis
The results of subacute and acute (24 h) exposure
were tested for significance with one-way ANOVA. For
the results of the immediate treatment (pre- and post-
application data), repeated measure ANOVA was used.
Post hoc analysis was done by LSD with p < 0.05 as
limit.
The principles of the Ethical Committee for the Pro-
tection of Animals in Research of the University were
strictly followed throughout.
3. Results
3.1. Effects of 3-NP on the parameters of the
cortical evoked potential
The latency and duration of the cortical EP were
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Fig. 1. Effect of 3-NP on the latency (lat.) and duration (dur.) of
somatosensory evoked potentials in acute (A) and subacute (B) appli-
cation. Ordinate: length of latency and duration (mean + S.D.,n = 10).
*p < 0.05, **p < 0.01, respectively, vs. untreated control.
(Fig. 2A) but neither 3-NP administration nor the inter-
stimulus interval had a noteworthy effect on this param-
eter. In the latency, of the second/first ratio in treated
versus control animals was somewhat (but not signifi-
cantly) different. In immediate effect, the second/first
ratio of the amplitude depended on the time elapsed as
well as on ISI (Fig. 2B). In the control period, the ratio
was around 0.5. After injection of 3-NP, the ratio started
to increase (i.e. the second response was less impeded
by the first stimulus) and considerably surpassed 1.0.
At the two longest ISIs, the increase became significant
by the end of recording. In the same rats, the latency
ratio seemed to be influenced by 3-NP only from ca.
the 100th minute on (Fig. 2C); this change, however,
remained below the level of significance.
3.2. Effect of 3-NP on the tail nerve action
potential
In the subacutely treated rats, the latency of the
tail nerve action potential was longer than in theeasured after acute and subacute 3-NP administra-
ion. In 24 h after the injection, no considerable change
ould be observed in the latency, however, the duration
f the potentials significantly increased (Fig. 1A). In the
ubacute experiment, the latency of the EPs increased
ithout any alteration in the duration (Fig. 1B).
When the stimulus train was repeated with shorter
eriod time (100 instead of 1000 ms), latency and dura-
ion of the somatosensory EPs both increased. In rats
ith subacute 3-NP treatment, the latency increase
eemed to be non-significantly diminished while the
requency dependence of duration showed no change
pon 3-NP.
Another measure of interaction between individ-
al EPs, the second/first ratio, was investigated in the
cute experiments. The amplitude of the second EP,
n response to double-pulse stimulation of the whisker
ad, was considerably suppressed by the first response
A. Szabo´ et al. / Toxicology Letters 160 (2006) 212–217 215
Fig. 2. (A) Effect of acute 3-NP (20 mg/kg i.p., recorded in 24 h) on the second/first ratio of peak-to-peak amplitude (control (), treated (♦)) and
first peak latency (control (), treated ()) of the somatosensory evoked potential elicited by double-pulse stimulation at various interstimulus
intervals (abscissa). Ordinate: second/first ratio (mean, n = 10). (B) and (C) Effect of the interstimulus interval on the amplitude (B) and first
peak latency (C) of the somatosensory evoked potentials in rats before and immediately after i.p. application of 20 mg/kg 3-NP. Abscissa:
time (3-NP was given at 0 ms). Ordinate: second/first ratio (mean, n = 10). Insert in (B) interstimulus intervals for (B) and (C). *p < 0.05 vs.
pre-administration period.
controls. The frequency dependence of the latency
was moderate but indicated the impairment of the
excitation mechanism by 3-NP, because when the
period time was 10 and 50 ms, the latency difference
between treated and control rats was significant
(Fig. 3A). In the amplitude, the frequency dependence
was more marked but not significantly influenced
by 3-NP.
The alterations in the refractory period (investigated
by double-pulse stimulation) and conduction velocity
of the tail nerve were variable in the different protocols
(Section 2.2). In acute and subacute treatment, the
relative refractory period increased (significantly in
the latter; Fig. 3B). On immediate administration of
3-NP, the relative refractory period decreased from the
10th minute on (this change was below significance).
The absolute refractory period and the conduction
velocity showed no clear alteration in response
to 3-NP.
4. Discussion
The present experiments revealed that 3-NP caused
several alterations in the cortical and peripheral
evoked electrical activity. Of these, the changes in
the measured parameters of cortical and peripheral
evoked activity, and the frequency dependence of
these (known to be sensitive to toxic influences; Papp
et al., 2000a,b) are likely to be deduced to the same
ground, namely low energy supply. A main effect of
3-NP is to cause energy insufficiency in the neurons by
inhibiting mitochondrial oxidation (Coles et al., 1979).
In humans with inherited or idiopathic mitochondrial
dysfunction, like mitochondrial encephalomyopathy
(ME), cortical functions were affected (Montirosso
et al., 2002). The alteration of certain visual evoked
potential components in ME (Finsterer, 2001; Scaioli
et al., 1998) and the increased latency of evoked
potentials in rats subacutely treated with 3-NP, was
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Fig. 3. (A) Effects of varying the period time of the stimulation on
the latency of the tail nerve action potential in rats with subacute 3-
NP treatment. Abscissa: period time, ordinate: latency (mean + S.D.,
n = 10). (B) Effect of 3-NP on the relative refractory period of the tail
nerve in acute and subacute application. Ordinate: relative refractory
period (mean + S.D., n = 10). *p < 0.05 vs. untreated control.
similar. The stronger change of the cortical EP and
tail nerve action potential parameters with increasing
stimulation frequency, compared to the untreated
controls, also indicated a functional disturbance,
resulting probably from energy insufficiency.
The differences between the changes in the mea-
sured parameters of the EPs in subacute versus acute
3-NP treatment indicated, however, that other mecha-
nisms of action beyond (or instead of) mitochondrial
impairment might have played a role. 3-NP is known to
inhibit glutamate uptake (Tavares et al., 2001) possibly
leading to imbalance between excitation and inhibition,
which may explain the increased duration of corti-
cal evoked responses in acute 3-NP exposure. Excess
glutamate causes excitotoxicity (Pubill et al., 2001)
possibly reflected in the lengthened latency of evoked
potentials seen in the subacutely treated rats. It is worth
to note that, at the time of preparation and investigation,
the treated rats showed no signs of motor impairment
(some rolling and paresis was seen transiently, 3–4 h
after 3-NP injections).
The results obtained with double-pulse somatosen-
sory stimulation indicate a phenomenon that can be
regarded as a disinhibition. In human ME patients,
paired-pulse somatosensory stimulation delivered to
the median nerve revealed strongly reduced intra-
cortical inhibition (Liepert et al., 2001). In spite of
the human-to-animal differences; the similarity of the
effects, and the known relationship of mitochondrial
disorders and increased cortical excitability (Rosing et
al., 1985) suggest that double-pulse stimulation could
be used to reveal or to follow-up the action of mitochon-
drial toxins, including 3-NP, in a sensitive and specific
way.
The main findings of the study, namely: changes
of the latency and duration of somatosensory corti-
cal EPs, and of the latency and amplitude of the tail
nerve action potentials, as well as the stimulation fre-
quency dependence of these, and also the interaction of
responses evoked by double stimulation; most probably
reflected the known bichemical/neurochemical effects
of 3-NP. In further studies, the details of the relation-
ship between effects of 3-NP and the observed nervous
system effects are to be revealed. This, in turn, might
serve as a basis to work out more sensitive standard
measures for monitoring 3-NP based disease models,
and contribute to better understanding these.
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